Sugar-modified G-quadruplexes: effects of LNA-, 2′F-RNA– and 2′F-ANA-guanosine chemistries on G-quadruplex structure and stability

Journal article published in 2013 by Zhe Li, Christopher Jacques Lech, Anh Tuân PhanORCID

Full text: Download

Publisher: Oxford University Press (OUP) (Policy C - Option B)

Preprint: archiving allowed. Upload

Postprint: archiving allowed. Upload

Published version: archiving allowed. Upload

Policy details (opens in a new window). Data provided by SHERPA/RoMEO
G-quadruplex-forming oligonucleotides containing modified nucleotide chemistries have demonstrated promising pharmaceutical potential. In this work, we systematically investigate the effects of sugar-modified guanosines on the structure and stability of a (4+0) parallel and a (3+1) hybrid G-quadruplex using over 60 modified sequences containing a single-position substitution of 2'-O-4'-C-methylene-guanosine ((LNA)G), 2'-deoxy-2'-fluoro-riboguanosine ((F)G) or 2'-deoxy-2'-fluoro-arabinoguanosine ((FANA)G). Our results are summarized in two parts: (I) Generally, (LNA)G substitutions into 'anti' position guanines within a guanine-tetrad lead to a more stable G-quadruplex, while substitutions into 'syn' positions disrupt the native G-quadruplex conformation. However, some interesting exceptions to this trend are observed. We discover that a (LNA)G modification upstream of a short propeller loop hinders G-quadrupex formation. (II) A single substitution of either (F)G or (FANA)G into a 'syn' position is powerful enough to perturb the (3+1) G-quadruplex. Substitution of either (F)G or (FANA)G into any 'anti' position is well tolerated in the two G-quadruplex scaffolds. (FANA)G substitutions to 'anti' positions are better tolerated than their (F)G counterparts. In both scaffolds, (FANA)G substitutions to the central tetrad layer are observed to be the most stabilizing. The observations reported herein on the effects of (LNA)G, (F)G and (FANA)G modifications on G-quadruplex structure and stability will enable the future design of pharmaceutically relevant oligonucleotides.